2Saetta M,Turato G,Maestrelli P,et al.Cellular and structural bases of chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2001,163(6):1304-1309.
3Calverley P,Pauwels R,Vestbo J,et al.Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease:a randomised controlled trial.Lancet,2003,361(9356):449-456.
4Weersink EJ,Postma DS,Koeter GH,et al.Picumeterol:dissociation of improvement in lung function and reduction of airways hyperresponsiveness in asthmatics.Br J Clin Pharmacol,1997,43(2):169-176.
5Rohatagi S,Arya V,Zech K,et al.Population pharmacokinetics and pharmacodynamics of ciclesonide.J Clin Pharmacol,2003,43(4):365-378.
6Poole PJ,Black PN.Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease:systematic review.BMJ,2001,322(7297):1271-1274.
7Kellerman DJ.P2Y(2) receptor agonists:a new class of medication targeted at improved mucociliary clearance.Chest,2002,121(5 Suppl):201S-205S.
